Quantbot Technologies’s Trillium Therapeutics TRIL Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIL
Quantbot Technologies's TRIL Position: Q4 2021 in Review
Quantbot Technologies sold out of Trillium Therapeutics (TRIL) in Q4 2021, closing a stake of 6,900 shares — an estimated $121K sold.
Quantbot Technologies first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $121K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.
- Quantbot Technologies reported no remaining Trillium Therapeutics position as of Q4 2021 after selling out during the quarter.
- Quantbot Technologies sold 6,900 Trillium Therapeutics shares in Q4 2021, an estimated $121K.
- Quantbot Technologies first reported a position in Trillium Therapeutics in Q3 2021 and held it in 1 quarter.
- Quantbot Technologies's Trillium Therapeutics position peaked at $121K in Q3 2021.
- 2 funds tracked by Wall St. Rank held Trillium Therapeutics as of Q4 2021.
Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.